Cerecor Inc (CERC) Director Acquires $49,338.90 in Stock

Share on StockTwits

Cerecor Inc (NASDAQ:CERC) Director Armistice Capital, Llc purchased 12,651 shares of the company’s stock in a transaction on Friday, January 11th. The shares were bought at an average price of $3.90 per share, for a total transaction of $49,338.90. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Armistice Capital, Llc also recently made the following trade(s):

  • On Wednesday, January 9th, Armistice Capital, Llc bought 545 shares of Cerecor stock. The stock was acquired at an average price of $3.79 per share, for a total transaction of $2,065.55.
  • On Monday, January 7th, Armistice Capital, Llc bought 6,504 shares of Cerecor stock. The stock was acquired at an average price of $3.65 per share, for a total transaction of $23,739.60.
  • On Friday, January 4th, Armistice Capital, Llc bought 20,000 shares of Cerecor stock. The stock was acquired at an average price of $3.42 per share, for a total transaction of $68,400.00.
  • On Tuesday, December 31st, Armistice Capital, Llc bought 12,300 shares of Cerecor stock. The stock was acquired at an average price of $3.18 per share, for a total transaction of $39,114.00.
  • On Saturday, December 28th, Armistice Capital, Llc bought 26,499 shares of Cerecor stock. The stock was acquired at an average price of $3.12 per share, for a total transaction of $82,676.88.
  • On Monday, December 31st, Armistice Capital, Llc bought 12,300 shares of Cerecor stock. The stock was acquired at an average price of $3.18 per share, for a total transaction of $39,114.00.
  • On Friday, December 28th, Armistice Capital, Llc bought 26,499 shares of Cerecor stock. The stock was acquired at an average price of $3.12 per share, for a total transaction of $82,676.88.
  • On Monday, December 17th, Armistice Capital, Llc bought 14,938 shares of Cerecor stock. The stock was acquired at an average price of $3.26 per share, for a total transaction of $48,697.88.
  • On Friday, December 14th, Armistice Capital, Llc bought 28,032 shares of Cerecor stock. The stock was acquired at an average price of $3.33 per share, for a total transaction of $93,346.56.
  • On Monday, December 10th, Armistice Capital, Llc bought 13,815 shares of Cerecor stock. The stock was acquired at an average price of $3.36 per share, for a total transaction of $46,418.40.

CERC stock opened at $3.90 on Monday. Cerecor Inc has a 52-week low of $2.36 and a 52-week high of $5.74. The company has a current ratio of 0.74, a quick ratio of 0.70 and a debt-to-equity ratio of 0.74. The company has a market cap of $154.25 million, a PE ratio of 9.29 and a beta of 1.30.

Cerecor (NASDAQ:CERC) last announced its quarterly earnings data on Tuesday, November 13th. The company reported ($0.26) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.12) by ($0.14). Cerecor had a negative net margin of 241.29% and a negative return on equity of 75.94%. The company had revenue of $4.08 million for the quarter, compared to analysts’ expectations of $4.80 million. Equities research analysts anticipate that Cerecor Inc will post -1.09 EPS for the current fiscal year.

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc grew its position in Cerecor by 10.1% during the third quarter. Vanguard Group Inc now owns 87,929 shares of the company’s stock valued at $411,000 after purchasing an additional 8,094 shares in the last quarter. Cambridge Investment Research Advisors Inc. purchased a new position in Cerecor during the third quarter valued at approximately $169,000. Finally, BlackRock Inc. grew its position in Cerecor by 630.4% during the second quarter. BlackRock Inc. now owns 27,520 shares of the company’s stock valued at $120,000 after purchasing an additional 23,752 shares in the last quarter. 44.48% of the stock is currently owned by hedge funds and other institutional investors.

CERC has been the topic of a number of recent analyst reports. LADENBURG THALM/SH SH initiated coverage on shares of Cerecor in a report on Thursday, December 20th. They set a “buy” rating and a $9.00 price target on the stock. ValuEngine upgraded shares of Cerecor from a “hold” rating to a “buy” rating in a report on Thursday, November 1st. Finally, TheStreet upgraded shares of Cerecor from a “d” rating to a “c” rating in a report on Monday, November 12th.

ILLEGAL ACTIVITY WARNING: “Cerecor Inc (CERC) Director Acquires $49,338.90 in Stock” was first published by Week Herald and is the property of of Week Herald. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of US & international trademark and copyright laws. The legal version of this piece of content can be viewed at https://weekherald.com/2019/01/14/cerecor-inc-cerc-director-acquires-49338-90-in-stock.html.

Cerecor Company Profile

Cerecor Inc, a pharmaceutical company, focuses on pediatric health care. Its lead product portfolio includes prescribed dietary supplements, such as Poly-Vi-Flor and Tri-Vi-Flor; and prescription drugs, such as Millipre, Veripred, and Ulesfia for the treatment of inflammation of the skin, joints, lungs, and other organs, as well as asthma, allergies, arthritis, and head lice infestation.

See Also: Net Income

Insider Buying and Selling by Quarter for Cerecor (NASDAQ:CERC)

Receive News & Ratings for Cerecor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerecor and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply